DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/q5r89d/inhaled_drug) has announced the addition of the "Inhaled Drug Delivery to 2016" report to their offering.

Advances in drug formulation and inhalation device design are creating new opportunities for inhaled drug delivery as an alternative to oral and parenteral delivery methods. Nebulizers, metered dose inhalers (MDIs), and dry powder inhalers (DPIs) have each found a niche in the quest for optimal treatment and convenient use. While nebulizers have evolved relatively independently of the drug formulations they deliver, the current generation of MDIs and DPIs have been developed or tailored for the specific pharmaceutical being delivered, resulting in improved performance.

Several of the emerging drug products covered in this report will have a significant impact in the therapeutic markets they target, improving patient compliance and effectively changing the way important illnesses and conditions are treated.

Highlights

• Analyzes and evaluates inhaled drugs currently in development and assesses the market potential for existing and probable future products
• Examines inhalation device technology for commercial and development-stage devices, and evaluates product technology issues and evolving market factors
• Provides detailed assessments of targeted disease segments, forecast growth and market potential, and therapeutic options
• Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets and prescribing decisions to 2016

Key Topics Covered

Executive Summary

Inhaled Drug Market Dynamics

Therapeutic Targets

• Demographics and Growth
• Competing Technologies
• Market Drivers
• Factors Limiting Growth

Inhalation Technology & Product

Drug Formulations

• Formulation Technologies
• Excipients and Release Profiles
• Inhalation Device Design Factors
• Dry Powder Inhalers
• Metered Dose Inhalers
• Nebulizers
• Performance Factors
• Bioavailability
• Dose Reproducibility
• Active Compound Stability
• Combination Drug Inhalers
• Testing and Packaging
• Emerging Device Technologies

Inhalation Devices - Device

• Assessments and Product Strategies
• Dry Powder inhalers
• Commercial Devices
• Development-stage DPI Devices
• Metered Dose Inhalers
• Nebulizers
• Compressed Air Nebulizers
• Ultrasonic Nebulizers
• Advanced Technology Nebulizers

Inhaled Drugs - Therapeutic Segment

• Analysis & Forecasts
• Upper Respiratory Indications
• Asthma/COPD
• Allergic Rhinitis

Systemic Drug Delivery

• Anaphylaxis
• Bioterror
• Cardiovascular Medicine
• Diabetes
• Hereditary Diseases
• Immunology
• Infectious Diseases
• Osteoporosis
• Neurology
• Oncology
• Pain Management
• Sexual Health

Market Factors

• Device Packaging
• Regulatory Issues
• Patient Compliance
• The Role of CMOs/CSOs
• Healthcare Economics

Market Sector Company Profiles

For more information visit http://www.researchandmarkets.com/research/q5r89d/inhaled_drug

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.